
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | 2026-04-24 | RA CAPITAL MANAGEMENT, L.P. | Director | Sale | 165.2K | $15.77 | $2.60M | 2.40M | View ↗ | |
| 2026-04-20 | 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. | Director | Sale | 172.0K | $15.77 | $2.71M | 2.57M | View ↗ | |
| 2026-04-17 | 2026-04-21 | RA CAPITAL MANAGEMENT, L.P. | Director | Sale | 458.4K | $16.28 | $7.46M | 2.74M | View ↗ | |
| 2026-04-15 | 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. | Director | Sale | 53.6K | $16.01 | $859K | 3.20M | View ↗ | |
| 2026-04-14 | 2026-04-15 | RA CAPITAL MANAGEMENT, L.P. | Director | Sale | 153.7K | $15.97 | $2.46M | 3.25M | View ↗ |
No annual data found.
Wall Street Analysts Believe Vor Biopharma (VOR) Could Rally 124.59%: Here's is How to Trade
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Does Vor Biopharma (VOR) Have the Potential to Rally 117% as Wall Street Analysts Expect?
Vor Biopharma: It's A Game Of Wait And See